Highland Europe

Highland Europe invests in rapidly growing European internet, mobile, and software companies that address large market opportunities and have over €10 million in annualized revenues. They can provide acquisition finance or lead secondary transactions as well as making primary investments. Their capital enables management teams to accelerate growth and build a lasting, valuable business. Highland Europe was launched in 2012 and closely collaborates with Highland Capital Partners, an independent global venture capital firm with a twenty-seven year investment experience and offices in Boston and Palo Alto.

Jacob Bernstein

Principal

David Blyghton

Partner

Sam Brooks

Partner

Irena Goldenberg

General Partner

Fergal Mullen

Co-Founder and Partner

Helena Prokhorenko

Principal

Gajan Rajanathan

General Partner

Ronan Shally

Partner and CFO

Tony Zappala

Partner

Past deals in Maryland

ZeroFox

Series D in 2020
ZeroFox provides external cybersecurity solutions to help organizations identify, manage, and mitigate social media-based cyber threats. Its solutions protect organizations from the risks introduced by social networking and digital communication platforms. In an age of constant connectivity and social sharing, users have become the primary target for the adversary. By continuously monitoring social platforms for cyber attacks, information loss, social engineering campaigns, account compromise, and fraud, ZeroFox protects organizations from the next generation of digital threats. Leveraging cutting-edge technology and proven security practices, ZeroFox provides both targeted protection and global insights into the world of social media threats.

Xometry

Series D in 2019
Xometry is a AI-enabled marketplace for on-demand manufacturing, transforming one of the largest industries in the world. Xometry uses its proprietary technology to create a marketplace that enables buyers to efficiently source on-demand manufactured parts and assemblies, and empowers sellers of manufacturing services to grow their businesses.

Xometry

Series C in 2018
Xometry is a AI-enabled marketplace for on-demand manufacturing, transforming one of the largest industries in the world. Xometry uses its proprietary technology to create a marketplace that enables buyers to efficiently source on-demand manufactured parts and assemblies, and empowers sellers of manufacturing services to grow their businesses.

ZeroFox

Series C in 2017
ZeroFox provides external cybersecurity solutions to help organizations identify, manage, and mitigate social media-based cyber threats. Its solutions protect organizations from the risks introduced by social networking and digital communication platforms. In an age of constant connectivity and social sharing, users have become the primary target for the adversary. By continuously monitoring social platforms for cyber attacks, information loss, social engineering campaigns, account compromise, and fraud, ZeroFox protects organizations from the next generation of digital threats. Leveraging cutting-edge technology and proven security practices, ZeroFox provides both targeted protection and global insights into the world of social media threats.

Xometry

Series A in 2017
Xometry is a AI-enabled marketplace for on-demand manufacturing, transforming one of the largest industries in the world. Xometry uses its proprietary technology to create a marketplace that enables buyers to efficiently source on-demand manufactured parts and assemblies, and empowers sellers of manufacturing services to grow their businesses.

ZeroFox

Series B in 2015
ZeroFox provides external cybersecurity solutions to help organizations identify, manage, and mitigate social media-based cyber threats. Its solutions protect organizations from the risks introduced by social networking and digital communication platforms. In an age of constant connectivity and social sharing, users have become the primary target for the adversary. By continuously monitoring social platforms for cyber attacks, information loss, social engineering campaigns, account compromise, and fraud, ZeroFox protects organizations from the next generation of digital threats. Leveraging cutting-edge technology and proven security practices, ZeroFox provides both targeted protection and global insights into the world of social media threats.

Xometry

Seed Round in 2015
Xometry is a AI-enabled marketplace for on-demand manufacturing, transforming one of the largest industries in the world. Xometry uses its proprietary technology to create a marketplace that enables buyers to efficiently source on-demand manufactured parts and assemblies, and empowers sellers of manufacturing services to grow their businesses.

2U

Series D in 2013
2U is a cloud-based Software-as-a-Service platform providing schools with the comprehensive operating infrastructure they need to attract, enroll, educate, support, and graduate students globally. Blending live face-to-face classes, dynamic course content, and real-world learning experiences, 2U’s No Back Row approach ensures that every student can experience the high-quality university education for the most successful outcome. The platform partners with universities to offer online degree programs. 2U supplies universities with the tools, expertise, capital, and global recruiting needed to compete in a space currently dominated by unexceptional programs, while developing state-of-the-art technology platforms that enhance traditional offline curricula to create transformative instruction using the best educational and Web 2.0 technologies. The platform provides the vital logistical components of any online program, including comprehensive student support services from enrollment through graduation and beyond as well as practical learning experiences within distant communities around the country. 2U partners with colleges and universities to deliver the world’s best online degree programs so students everywhere can reach their full potential. It was launched in 2008 and is based in Hanover, M.D.

2U

Series D in 2012
2U, Inc. operates as an education technology company in the United States, Hong Kong, South Africa, and the United Kingdom. It operates in two segments, Graduate Program Segment and Short Course Segment. The Graduate Program Segment targets students seeking a full graduate degree. The Short Course Segment targets working professionals seeking career advancement through skills attainment. The company builds, delivers, and supports online graduate programs and certificates for working adults through its 2U Operating System, a platform that provides front-end and back-end cloud-based SaaS technology and technology-enabled services to university clients. The company was formerly known as 2Tor Inc. and changed its name to 2U, Inc. in October 2012. 2U, Inc. was founded in 2008 and is headquartered in Lanham, Maryland.

OpGen

Series C in 2012
OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious diseases. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life-threatening infections to improve patient outcomes. The company's approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). OpGen was established in 2002 by David Schwartz in Rockville, Maryland.

OpGen

Series B in 2010
OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious diseases. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life-threatening infections to improve patient outcomes. The company's approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). OpGen was established in 2002 by David Schwartz in Rockville, Maryland.

OpGen

Venture Round in 2007
OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious diseases. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life-threatening infections to improve patient outcomes. The company's approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). OpGen was established in 2002 by David Schwartz in Rockville, Maryland.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.